Hence, our results collectively suggest that in parallel with the APOE-ε4 coding risk factor, there are additional genetic risk factors in the APOE surrounding regions that can modulate both gene expression and AD-associated phenotypic outcomes, pointing towards new directions for studying the disease mechanisms of AD. The gene discussed is APOE; the disease is Alzheimer disease.